CTRI/2024/01/061801尚未招募未知
A prospective, interventional, and multi-center study to characterize the efficacy and performance of the 100% Silicone Foley Balloon Catheter 2-way, 100% Silicone Foley Balloon Catheter – BH model 2-way, and 100% Silicone Foley Balloon Catheter – Star/ Ribbed model 2-way - nil
Sterimed Group0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.All subjects who undergo urinary catheterization indicated for long term catheterization of minimum of 30 days
- •2.Both Male and Female patients will be enrolled
- •3.All patients who are willing to provide informed consent for participation in the study
排除标准
- •1.Subjects not suitable for intervention with silicone Foley catheter
- •2.All subjects who are not willing to provide informed consent for participation in the study
- •3.Pediatric population
- •4.Neurogenic bladder condition subjects
- •5.Immobilized subjects
- •6.Subjects having urethral strictures
研究者
相似试验
进行中(未招募)
4 期
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.CTRI/2017/10/010218ovo Nordisk India Private Ltd
已完成
不适用
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practiceG35.1DRKS00029567Biogen GmbH118
已完成
4 期
Clinical Study of fixed dose combination of FLUCOLD TABLET in the Treatment of common cold and flu in adult populatioCTRI/2020/07/026402Wallace Pharmaceuticals Pvt Ltd199
已完成
4 期
Clinical Study of fixed dose combination of FLUCOLD DROPS in the Treatment of common cold and flu syndrome in infants and childreCTRI/2020/06/026109Wallace Pharmaceuticals Pvt Ltd220
已完成
4 期
Clinical Study of fixed dose combination of FLUCOLD SYRUP in the Treatment of common cold and flu symptoms in childreCTRI/2020/06/026248Wallace Pharmaceuticals Pvt Ltd204
